The use of aspirin for the treatment of pre-eclampsia: a narrative review

Abstract

Objective: To clarify aspects of pre-eclampsia, it's possible complications and the effect of aspirin as a form of treatment for this syndrome. Bibliographic review: The benefit of aspirin administration in women with risk factors is obtained, as a way to prevent pre-eclampsia and fetal growth restriction, without potential maternal and fetal risks. The dose of aspirin used to reduce the incidence of pre-eclampsia ranges from 50 to 150mg/day, depending on the study analyzed. However, when analyzing the most recommended doses, we can infer that the most recommended and used dose is 100mg/day. Final considerations: The intercurrent hypertensive syndrome in pregnancy, known as pre-eclampsia, induces a risk of significant implications for gestational and fetal health, which can lead to maternal and perinatal death or generate definite limitations on the health of both. Therefore, it is important to study resources aimed at prevention, risk factors and possible complications resulting from such a clinical condition, such as aspirin.